These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 15474696

  • 1. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 2. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 3. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
    Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M.
    Cardiovasc Diabetol; 2003 Nov 28; 2():16. PubMed ID: 14641923
    [Abstract] [Full Text] [Related]

  • 4. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov 28; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 5. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 28; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 7. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 05; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 8. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 05; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 9. Clinical benefits of trimetazidine in patients with recurrent angina.
    Szwed H.
    Coron Artery Dis; 2004 May 05; 15 Suppl 1():S17-21. PubMed ID: 15179124
    [Abstract] [Full Text] [Related]

  • 10. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL.
    Cardiologia; 1999 Dec 05; 44(12):1065-9. PubMed ID: 10687257
    [Abstract] [Full Text] [Related]

  • 11. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 12. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov 09; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 13. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 09; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 09; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 15. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
    Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.
    Heart; 2011 Sep 09; 97(18):1495-500. PubMed ID: 21700755
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV).
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep 09; 33(9):793-5. PubMed ID: 16266453
    [Abstract] [Full Text] [Related]

  • 17. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
    Sonntag S, Sundberg S, Lehtonen LA, Kleber FX.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2177-82. PubMed ID: 15193677
    [Abstract] [Full Text] [Related]

  • 18. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.
    Witte KK, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, Clark AL, Cleland JG.
    Eur Heart J; 2005 Nov 16; 26(21):2238-44. PubMed ID: 16081469
    [Abstract] [Full Text] [Related]

  • 19. Effect of medical therapy on left ventricular ejection fraction in patients with systolic heart failure and narrow QRS duration with and without ischemic heart disease and left ventricular mechanical dyssynchrony.
    Nair CK, Shen X, Aronow WS, Li H, Holmberg MJ, Korlakunta H, Hee T, Maciejewski S, Esterbrooks DJ.
    Am J Ther; 2010 Nov 16; 17(1):e1-7. PubMed ID: 19262361
    [Abstract] [Full Text] [Related]

  • 20. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004 Nov 16; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.